Skip to main content
Top
Published in: Neurological Sciences 1/2020

01-01-2020 | Human Alphaherpesvirus 3 | Letter to the Editor

Seronegative limbic encephalitis

Authors: Álvaro Sánchez-Larsen, Carlos de Cabo

Published in: Neurological Sciences | Issue 1/2020

Login to get access

Excerpt

We describe the case of a left-handed 42-year-old woman without relevant diseases, who initially presented with fever (39.5 °C) and headache. This was followed by an acute, severe anterograde and retrograde (working memory) deficit 5 days later, when she was admitted to our hospital. She then started with frequent (up to 10 per day) focal aware non-motor seizures that commenced with an aura characterized by left hemicranial headache followed by bradypsychia, cold sensation and shivering, goosebumps and piloerection of the left limbs, and facial flushing. Brain MRI showed bilateral asymmetric (left more than right) abnormalities in both temporal lobes (edema and hyperintensity of mesial temporal structures and insular cortex) (Fig. 1). Electroencephalography (EEG) monitoring confirmed that previous seizures originated at both temporal lobes with a left predominance; however, subclinical temporal seizures were also recorded. Lumbar puncture showed mild protein increase in cerebrospinal fluid (CSF) (0.68 g/L), mild pleocytosis (6 cells/mm3), normal glucose, and negative PCR for virus and negative cultures. The whole battery of systemic antibodies was negative: antinuclear antibodies (ANA), anti-extractable nuclear antigen antibodies (ENAS) (Sm, RNP, Ro-SSA, La-SSB, Jo-1, Scl-70, PCNA, PM-Scl, ribosomal-P, centromeres), antithyroid peroxidase, antithyroglobulin, anti-transglutaminase, and anti-GAD antibodies. Serological status was negative for acute infection both in serum and CSF, from toxoplasma, cytomegalovirus, Epstein-Barr virus, herpes simplex virus (VHS), varicella zoster virus (VZV), Cryptococcus, hepatitis A, B, and C virus, and human immunodeficiency virus (HIV). No antineuronal antibodies were detected either in CSF (Anti-NMDAR, AMPAR, GABAbR, GABAaR, DPPX, LGI1, CASPR2, mGluR5, mGluR1, neurexin antibodies) or in blood (anti-amphiphysin, CV2/CRMP5, PNMA2/Ma2/Ta, Ri/ANNA2, Yo/PCA1, Hu/ANNA1, Tr/DNER, ZIC, SOX1, GAD antibodies). A negative, whole-body computed tomography (CT) scan study ruled out a hidden tumor; tumor markers were also negative. A whole-body fluorodeoxyglucose positron emission tomography (FDG-PET) scan showed hypermetabolism in the left temporal lobe. Levetiracetam, lacosamide, valproate, carbamazepine, clonazepam, and topiramate were tested without efficacy in seizure control. Furthermore, five pulses of IV methylprednisolone were administered without improvement. Finally, after 5 doses of IV gamma globulin, cognitive alteration started to improve, and seizures were controlled. A brain MRI performed 8 months after the episode showed resolution of the acute alterations and a left hippocampal atrophy without clear sclerosis (Fig. 2). During the follow-up period (26 months), repeated complementary tests (tumor markers, mammography, abdominal and gynecologic ultrasound scans, whole-body CT scans) excluded an underlying tumor. However, a drug-resistant, bi-temporal epilepsy and mild cognitive decline have persisted to the present.
Appendix
Available only for authorised users
Literature
1.
go back to reference Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404CrossRef Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Prüss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostásy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404CrossRef
2.
go back to reference Graus F, Escudero D, Oleaga L, Bruna J, Villarejo-Galende A, Ballabriga J, Barceló MI, Gilo F, Popkirov S, Stourac P, Dalmau J (2018) Syndrome and outcome of antibody-negative limbic encephalitis. Eur J Neurol 25:1011–1016CrossRef Graus F, Escudero D, Oleaga L, Bruna J, Villarejo-Galende A, Ballabriga J, Barceló MI, Gilo F, Popkirov S, Stourac P, Dalmau J (2018) Syndrome and outcome of antibody-negative limbic encephalitis. Eur J Neurol 25:1011–1016CrossRef
3.
go back to reference Steriade C, Moosa ANV, Hantus S, Prayson RA, Alexopoulos A, Rae-Grant A (2018) Electroclinical features of seizures associated with autoimmune encephalitis. Seizure. 60:198–204CrossRef Steriade C, Moosa ANV, Hantus S, Prayson RA, Alexopoulos A, Rae-Grant A (2018) Electroclinical features of seizures associated with autoimmune encephalitis. Seizure. 60:198–204CrossRef
4.
go back to reference López-Chiriboga AS, Flanagan EP (2018) Diagnostic and therapeutic approach to autoimmune neurologic disorders. Semin Neurol 38:392–402CrossRef López-Chiriboga AS, Flanagan EP (2018) Diagnostic and therapeutic approach to autoimmune neurologic disorders. Semin Neurol 38:392–402CrossRef
5.
go back to reference Zuliani L, Nosadini M, Gastaldi M, Spatola M, Iorio R, Zoccarato M, Mariotto S, de Gaspari P, Perini F, Ferrari S, Evoli A, Sartori S, Franciotta D, Giometto B (2019) Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations. Neurol Sci 3. https://doi.org/10.1007/s10072-019-03930-3 CrossRef Zuliani L, Nosadini M, Gastaldi M, Spatola M, Iorio R, Zoccarato M, Mariotto S, de Gaspari P, Perini F, Ferrari S, Evoli A, Sartori S, Franciotta D, Giometto B (2019) Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations. Neurol Sci 3. https://​doi.​org/​10.​1007/​s10072-019-03930-3 CrossRef
6.
go back to reference van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13:290–301CrossRef van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13:290–301CrossRef
Metadata
Title
Seronegative limbic encephalitis
Authors
Álvaro Sánchez-Larsen
Carlos de Cabo
Publication date
01-01-2020
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 1/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04011-1

Other articles of this Issue 1/2020

Neurological Sciences 1/2020 Go to the issue